Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-02

Clinical Trial Update: Study on Safety and Effectiveness of Ergoferon in the Treatment of Flu / ARVI in Outpatients.

View source ↗

Summary

Clinical trial assessing safety and effectiveness of Ergoferon for viral respiratory infection in outpatients has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ergoferon

Snippet

Sponsor: Materia Medica Holding | Conditions: Viral Respiratory Infection | Status: COMPLETED | Results posted: 2021-04-02